Rapid Micro Biosystems, Inc. (RPID) Misses Q4 EPS by 3c

Go back to Rapid Micro Biosystems, Inc. (RPID) Misses Q4 EPS by 3c

Rapid Micro Biosystems Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Full Year 2023 Guidance

March 3, 2023 7:00 AM EST

Reports fourth quarter 2022 commercial revenue of $4.4 million

Reports full year 2022 commercial revenue of $17.1 million

Delivered full year 2022 recurring commercial revenue of $11.0 million, representing 40% growth

Provides full year 2023 commercial revenue guidance of at least $22.0 million, representing growth of... More